Fmr LLC Genmab A/S Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Genmab A/S stock. As of the latest transaction made, Fmr LLC holds 245,118 shares of GMAB stock, worth $6.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

245,118

Previous 374,407 34.53%

Holding current value

$6.49 Million

Previous $11.2 Million 45.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$25.13 - $30.27 $3.25 Million - $3.91 Million	-129,289 Reduced 34.53%	245,118 $6.16 Million
Q1 2024 May 13, 2024	BUY	$26.43 - $32.77 $2.83 Million - $3.5 Million	106,902 Added 39.96%	374,407 $11.2 Million
Q4 2023 Feb 13, 2024	SELL	$27.94 - $35.44 $4.33 Million - $5.49 Million	-154,932 Reduced 36.68%	267,505 $8.52 Million
Q3 2023 Nov 13, 2023	BUY	$35.27 - $42.24 $879,492 - $1.05 Million	24,936 Added 6.27%	422,437 $14.9 Million
Q2 2023 Aug 11, 2023	BUY	$37.4 - $42.94 $227,766 - $261,504	6,090 Added 1.56%	397,501 $15.1 Million
Q1 2023 May 11, 2023	SELL	$34.88 - $43.22 $2.1 Million - $2.6 Million	-60,248 Reduced 13.34%	391,411 $14.8 Million
Q4 2022 Feb 13, 2023	BUY	$33.8 - $47.06 $495,541 - $689,946	14,661 Added 3.35%	451,659 $19.1 Million
Q3 2022 Nov 10, 2022	BUY	$31.52 - $373.61 $6.02 Million - $71.4 Million	191,071 Added 77.69%	436,998 $14 Million
Q2 2022 Aug 12, 2022	BUY	$26.83 - $38.57 $679,335 - $976,592	25,320 Added 11.48%	245,927 $7.99 Million
Q1 2022 May 13, 2022	BUY	$30.95 - $39.68 $2.08 Million - $2.67 Million	67,258 Added 43.86%	220,607 $7.98 Million
Q4 2021 Feb 14, 2022	BUY	$35.87 - $47.12 $769,734 - $1.01 Million	21,459 Added 16.27%	153,349 $6.07 Million
Q3 2021 Nov 15, 2021	BUY	$41.55 - $48.72 $801,915 - $940,296	19,300 Added 17.14%	131,890 $5.76 Million
Q2 2021 Aug 13, 2021	BUY	$32.88 - $44.57 $3.7 Million - $5.02 Million	112,590 New	112,590 $4.6 Million

Others Institutions Holding GMAB

# of Institutions

232

Shares Held

48.5M

Call Options Held

6.8K

Put Options Held

27.6K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $17.4B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account